Stay updated on Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial
Sign up to get notified when there's something new on the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page.

Latest updates to the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page
- Check6 days agoChange DetectedThe page now shows Revision: v3.6.3, updating the revision history to reflect a newer page version.SummaryDifference0.1%

- Check13 days agoChange DetectedThe record history shows a new system revision label v3.6.2, replacing the previous v3.6.0.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRecruitment status changed to 'No longer looking for participants,' indicating enrollment has ended. The page history also notes a new release version, v3.6.0.SummaryDifference0.5%

- Check34 days agoChange DetectedNew revision entry v3.5.5 appears in the history. The previous revision v3.5.4 is removed from the history list.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision label updated to v3.5.4, indicating a new site release. This reflects a platform/UI update rather than changes to study data or page content.SummaryDifference0.1%

- Check70 days agoChange DetectedThe history now marks the study as Terminated with < 75% participation, replacing the previous Active, not recruiting status, with a last update date of 2026-04-27; the history also introduces new sections and a new revision (v3.5.3) in the record.SummaryDifference0.9%

Stay in the know with updates to Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page.